Molar Pregnancy and hCG
The highest-stakes hCG story: extreme levels, the follow-to-zero rule, and why caught early means cured.
A molar pregnancy (hydatidiform mole) is a pregnancy in which trophoblast tissue — the tissue that normally becomes the placenta — grows abnormally, usually because of an error at fertilization. In a complete mole, there is no embryo at all; in a partial mole, abnormal placental tissue grows alongside an embryo that cannot survive. Molar pregnancies occur in roughly 1 in 1,000 pregnancies and are nobody's fault.
Trophoblast tissue is the hCG factory — and molar tissue is that factory with the throttle stuck open. Molar pregnancies often produce extremely high hCG, frequently above 100,000 mIU/mL. That is why very high levels with severe nausea and vomiting (the hCG-thyroid connection at work), unusual bleeding, or a uterus larger than dates always put molar pregnancy on the list. It is also behind two testing quirks covered elsewhere on this site: the hook effect, where hCG is so high the test turns falsely negative, and the differential for extreme values on the levels page. In a study of failed pregnancies, hCG above 16,435 mIU/mL at 6-7 weeks and above 64,911 at 8-9 weeks pointed strongly toward complete mole rather than ordinary miscarriage.
Treatment is uterine evacuation. Then comes the part patients are least prepared for: hCG surveillance until the level is undetectable, and for a period after. The reason is serious but manageable: in a minority of cases (about 15-20% after complete moles, fewer after partial), molar tissue persists or regrows — gestational trophoblastic neoplasia (GTN) — announced by an hCG that plateaus or rises instead of falling. Caught by surveillance, GTN is one of oncology's great success stories, with cure rates approaching 100% with chemotherapy. This is why skipping surveillance draws is the one truly dangerous shortcut, and why pregnancy must wait until surveillance is complete: a new pregnancy's hCG would blind the monitoring.